Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
06/1999
06/16/1999CN1219967A Glial cell line-derived neurotrophic factor receptor
06/16/1999CN1219965A Promotion of regeneration of organized tissues
06/16/1999CN1219938A Conjugates of lipophilic moieties and fragments of vasoactive intestinal peptide (VIP)
06/16/1999CN1219936A New triazolopurines, method of preparing them and their use as drugs
06/16/1999CN1219930A Benzoxazinone dopamine D4 receptor antagonists
06/16/1999CN1219928A Novel vitamin D analogues
06/16/1999CN1219879A Pharmaceutical compositions
06/16/1999CN1219878A Method for treating pain
06/16/1999CN1219876A Method for treating migraine pain
06/16/1999CN1219875A Hexahydro-pyrido (4,3-B) indole derivatives as antipsychotic drugs
06/16/1999CN1043645C New benzothiadiazine compound, process for its preparation and pharmaceutical compositions which contain it
06/16/1999CN1043641C Hydroisoquinoline derivatives
06/16/1999CN1043639C New piperidine compounds, process for their preparation and pharmaceutical compositions which contain them
06/16/1999CN1043609C Process for preparing pharmaceutical composition containing benzothiazole compounds
06/15/1999US5912348 Isomerization promoted with bases
06/15/1999US5912345 Process for the preparation of lamotrigine
06/15/1999US5912335 A polynucleotide sequence that codes human 7-transmembrane receptor protein; treatment of infections, hiv, eating disorders, cancers, heart diseases, mental illnesses, huntington's disease, tourett's and parkinson's disease
06/15/1999US5912271 Local anaesthetic agents, a polar lipid, a triacylglycerol and optionally water.
06/15/1999US5912262 Heterocyclic compounds
06/15/1999US5912260 Gastrin and CCK antagonists
06/15/1999US5912259 Nonsteroid antiinflammatory agents for nervous system disorders
06/15/1999US5912250 Use of immunosuppressive agents for the treatment of schizophrenia
06/15/1999US5912246 Treatment for schizophenia, psychosis and other psychological disorders; dopamine antagonists
06/15/1999US5912245 Ampa and kainate antagonists.
06/15/1999US5912242 N-(4-substituted-benzyl)-2-aminolactam derivatives
06/15/1999US5912168 CD95 regulatory gene sequences
06/15/1999US5912143 Polynucleotides encoding a human mage protein homolog
06/15/1999US5912122 A polynucleotide coding for a central nervous system g protein receptor; therapy for neurodegenerative disorders
06/15/1999US5912005 Methods of use of uncoated gel particles
06/15/1999CA2161641C Stable, ingestable and absorbable nadh and nadph therapeutic compositions
06/15/1999CA2155664C Oxindole 1-[n-(alkoxycarbonyl)]carboxamides and 1-(n-carboxamido)carboxamides as antiinflammatory agents
06/15/1999CA2001083C Novel s-timolol derivative and process for its preparation
06/10/1999WO1999028493A2 Method for identifying inhibitors of g-protein coupled receptor hibef51
06/10/1999WO1999028492A1 A method of finding agonist and antagonist to human 11cb splice variant
06/10/1999WO1999028456A1 Splice variants for human 5-ht4 serotonin receptor and their applications, in particular for screening
06/10/1999WO1999028454A1 An active hedgehog-protein-mutant, a process for its preparation and its use for pharmaceutical purposes
06/10/1999WO1999028443A1 Lineage restricted glial precursors from the central nervous system
06/10/1999WO1999028343A2 Hydrophobically-modified protein compositions and methods
06/10/1999WO1999028342A2 Low-voltage activated calcium channel compositions and methods
06/10/1999WO1999028320A1 2-aryl-8-oxodihydropurine derivatives, process for producing the same, medicinal compositions containing the same, and intermediates thereof
06/10/1999WO1999028318A1 Amino-benzothiazole derivatives
06/10/1999WO1999028316A1 Thiophene-sulfonamide compounds
06/10/1999WO1999028310A1 Pseudopolymorphic forms of 2-[2-[4-[bis (4-fluorophenyl) methyl]-1-piperazinyl] ethoxy]acetic acid dihydrochloride
06/10/1999WO1999028309A1 1,3,4-thiadiazoles derivatives as kyn-oh inhibitors
06/10/1999WO1999028306A1 Benzenesulfonamide compounds
06/10/1999WO1999028300A1 Substituted imidazole derivatives having agonist-like activity at alpha 2b or 2b/2c adrenergic receptors
06/10/1999WO1999027949A1 METHOD OF SUPPRESSING β-AMYLOID-RELATED CHANGES IN ALZHEIMER'S DISEASE
06/10/1999WO1999027944A1 Prevention and treatment of amyloidogenic disease
06/10/1999WO1999027943A1 Use of ginkgo biloba extracts for preparing a medicine
06/10/1999WO1999027919A2 Cyp2a enzymes and their use in therapeutic and diagnostic methods
06/10/1999WO1999027905A1 Compositions for nasal administration
06/10/1999WO1999027890A2 A process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs
06/10/1999WO1999027801A1 Revitalisation formulation
06/10/1999WO1999018105A8 Dipyridoimidazolderivatives useful in treating central nervous system disorders
06/10/1999WO1999015684A3 Expression of genes in hematopoietic stem cells in hischaemic conditions
06/10/1999WO1999015659A3 Human ubiquitin-conjugating enzymes
06/10/1999WO1999004765A3 Pharmaceutical compositions containing an effervescent acid-base couple
06/10/1999CA2313050A1 Amino-benzothiazole derivatives
06/10/1999CA2312920A1 Prevention and treatment of amyloidogenic disease
06/10/1999CA2312851A1 Therapeutic and diagnostic methods dependent on cyp2a enzymes
06/10/1999CA2312334A1 Substituted imidazole derivatives having agonist-like activity at alpha 2b or 2b/2c adrenergic receptors
06/10/1999CA2312195A1 Low-voltage activated calcium channel compositions and methods
06/10/1999CA2312009A1 An active hedgehog-protein-mutant, a process for its preparation and its use for pharmaceutical purposes
06/10/1999CA2311682A1 Lineage restricted glial precursors from the central nervous system
06/10/1999CA2310541A1 Splice variants for human 5-ht4 serotonin receptor and their applications, in particular for screening
06/10/1999CA2310054A1 Thiophene-sulfonamide compounds
06/10/1999CA2310008A1 1,3,4-thiadiazoles derivatives as kyn-oh inhibitors
06/10/1999CA2309969A1 Benzenesulfonamide compounds
06/10/1999CA2309806A1 Hydrophobically-modified protein compositions and methods
06/09/1999EP0921197A2 Human disintegrin metalloprotease related to drosophila kuz gene
06/09/1999EP0920869A1 Stable aspirin-containing preparations for external use
06/09/1999EP0920630A2 Prion protein binding proteins and uses thereof
06/09/1999EP0920523A1 Hsv strain lacking functional icp27 and icp34.5 genes
06/09/1999EP0920515A1 A NOVEL HUMAN mRNA EDITING ENZYME
06/09/1999EP0920507A2 Secreted proteins and polynucleotides encoding them
06/09/1999EP0920506A1 Human dbi/acbp-like protein
06/09/1999EP0920504A2 Voltage-gated calcium channel antagonist and methods
06/09/1999EP0920448A1 Truncated glial cell line-derived neurotrophic factor
06/09/1999EP0920444A1 C-TERMINAL MODIFIED (N-SUBSTITUTED)-2-INDOLYL DIPEPTIDES AS INHIBITORS OF THE ICE/ced-3 FAMILY OF CYSTEINE PROTEASES
06/09/1999EP0920429A1 Substituted pyrido- or pyrimido-containing 6,6- or 6,7-bicyclic derivatives
06/09/1999EP0920424A1 Non-peptide bombesin receptor antagonists
06/09/1999EP0920423A1 Disubstituted morpholine, oxazepine or thiazepine derivatives, their preparation and their use as dopamine d4 receptor antagonists
06/09/1999EP0920422A1 Crytalline form of 4-[5-methyl-3-phenylisoxazol-4-yl]benzenesulfonamide
06/09/1999EP0920417A1 Il-8 receptor antagonists
06/09/1999EP0920330A1 hCG AND DERIVATIVES AS MATRIX METALLOPROTEASES INHIBITORS
06/09/1999EP0920323A1 Novel use of phospholipids of animal origin in therapy and/or dietetics
06/09/1999EP0920319A1 Antagonists of gonadotropin releasing hormone
06/09/1999EP0920318A1 Aryloxy- and arylthiosubstituted pyrimidines and triazines and derivatives thereof
06/09/1999EP0920316A1 Treatment of psychotic disorders
06/09/1999EP0920253A1 Il-8 receptor antagonists
06/09/1999EP0784613B1 Colchicine derivatives and the therapeutical use thereof
06/09/1999EP0752981B1 Substituted cyclopentylamine derivatives and their use as calcium channel antagonists
06/09/1999EP0751932B1 Vitamin-d amide derivatives
06/09/1999EP0734260B1 Paroxetine tablets and process to prepare them
06/09/1999CN1219172A Novel benzo-1,3-dioxolyl- and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists
06/09/1999CN1219171A Benzofuran carboxamides and their therapeutic use
06/09/1999CN1219170A Substituted 1,2,3,4-tetrahydronaphthalene derivatives
06/09/1999CN1219169A Substituted benzylamines and their use for the treatment of depression
06/09/1999CN1219133A Administration of polypeptide growth factors following central nervous system ischemia or trauma
06/09/1999CN1218801A Tri-substituted imidazoles, and process of their preparation and using the same and having their pharmic composition
1 ... 1552 1553 1554 1555 1556 1557 1558 1559 1560 1561 1562 1563 1564 1565 1566 1567 1568 1569 1570 1571 1572 ... 1833